• Genedx highlighted new peer-reviewed clinical results published in Genetics in Medicine; findings were presented as already published, not upcoming.
• Study at Seattle Children’s supports hospital-wide use of rapid genome sequencing as a first-line inpatient test beyond intensive care.
• Results showed more diagnoses with earlier answers, driving changes in patient management while improving hospital workflow without major staffing expansion.
• Analysis also indicated broader inpatient access reduced outpatient genetics bottlenecks, with access disparities by race eliminated within the program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260824639564) on August 24, 2026, and is solely responsible for the information contained therein.